Cargando…

Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer

PURPOSE: To investigate the relationship between early treatment response to definitive chemoradiotherapy (CRT) and survival outcome in patients with limited stage small cell lung cancer (LS-SCLC). MATERIALS AND METHODS: We retrospectively reviewed 47 patients with LS-SCLC who received definitive CR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Joohwan, Lee, Jeongshim, Choi, Jinhyun, Kim, Jun Won, Cho, Jaeho, Lee, Chang Geol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493423/ https://www.ncbi.nlm.nih.gov/pubmed/26157681 http://dx.doi.org/10.3857/roj.2015.33.2.117

Ejemplares similares

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors
por: Lee, Jeongshim, et al.
Publicado: (2016)

The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer
por: Sun, Chang, et al.
Publicado: (2022)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
por: Ha, In-Bong, et al.
Publicado: (2013)

Early hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis
por: Kim, Nalee, et al.
Publicado: (2016)

The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
por: Koo, Tae Ryool, et al.
Publicado: (2014)

Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
por: Kim, Hyun Ju, et al.
Publicado: (2017)

Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
por: Cha, Hyejung, et al.
Publicado: (2013)

Role of radiotherapy for pancreatobiliary neuroendocrine tumors
por: Lee, Jeongshim, et al.
Publicado: (2013)

Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy
por: Park, Sangjoon, et al.
Publicado: (2018)

Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients
por: Cho, Yeona, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
por: Lee, Jeongshim, et al.
Publicado: (2016)

Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Yeom, Jun Gi, et al.
Publicado: (2021)

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy
por: Guo, Jianping, et al.
Publicado: (2020)

Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy
por: Moon, Seung Hwan, et al.
Publicado: (2015)

Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
por: Kim, Jun Won, et al.
Publicado: (2016)

Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer
por: Corso, Christopher D., et al.
Publicado: (2015)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy
por: Kim, Seijong, et al.
Publicado: (2022)

The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer
por: Lee, Hyebin, et al.
Publicado: (2016)

Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy
por: Wen, Qiang, et al.
Publicado: (2017)

Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
por: Kang, Ki Mun, et al.
Publicado: (2012)

Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
por: Park, Junhee, et al.
Publicado: (2018)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
por: Kong, Moonkyoo, et al.
Publicado: (2012)

Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type
por: Kang, Jun-Hyeok, et al.
Publicado: (2020)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
por: Lee, Soo Jin, et al.
Publicado: (2022)

The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
por: Kucuk, Ahmet, et al.
Publicado: (2020)

The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
por: Demir, Metin, et al.
Publicado: (2022)

Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
por: Song, Jin Ho, et al.
Publicado: (2017)

Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
por: Lin, Jhen-Bin, et al.
Publicado: (2019)

Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer
por: Choi, Jinhyun, et al.
Publicado: (2015)

Prognostic Significance of the Lymph Node Ratio Regarding Recurrence and Survival in Rectal Cancer Patients Treated with Postoperative Chemoradiotherapy
por: Kim, Ji-Yoon, et al.
Publicado: (2012)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Role of local treatment including radiotherapy in Barcelona Clinic of Liver Cancer stage C patients: a nationwide cohort analysis in South Korea
por: Lee, Jeongshim, et al.
Publicado: (2019)

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
por: Vrankar, Martina, et al.
Publicado: (2020)

Prognostic Factors and Survival in Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy
por: Crvenkova, Simonida
Publicado: (2015)

Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus
por: Zhao, Kaikai, et al.
Publicado: (2021)

Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma
por: Choi, Jinhyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jiunq7chhgobbbif88b1j7co1r